The Valley Desk

NCT01464476 · Interventional trial

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)

Overall registry status Terminated

Phase 3

Conditions Arrhythmias, Cardiac, Cardiovascular Diseases, Heart Diseases, Implantable Cardioverter Defibrillator

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov